Argentine health authorities Thursday announced that the Japanese-developed TAK-003 vaccine against dengue was already ... muscle pain or weakness, and fever, and its use is disadvised among ...
Under pressure to rebuild as sales of its blockbuster Lantus slide, Sanofi desperately needed the launch of its Dengue vaccine to run smoothly. But it hasn’t. Analysts had expected blockbuster ...
As climate change accelerates, the spread of dengue fever is becoming more widespread ... public education, and vaccination, citing dengue’s resurgence as a major public health concern.
The increasing number of dengue fever cases is anticipated to drive the growth of the dengue vaccine market in the coming years. For example, in May 2024, the World Health Organization ...
Argentina has recorded 106 confirmed dengue-caused deaths so far this year Health Ministers from Argentina's 24 districts (23 provinces plus the Autonomous City of Buenos Aires -CABA-) convened ...
Infections have increased dramatically over the past two years while, at the same time, developers of anti-dengue drugs and vaccines have abandoned their research and development efforts.